Antibody responses to SARS-CoV-2 in patients with COVID-19 - PubMed (original) (raw)
. 2020 Jun;26(6):845-848.
doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
Bai-Zhong Liu # 2, Hai-Jun Deng # 1, Gui-Cheng Wu # 3 4, Kun Deng # 5, Yao-Kai Chen # 6, Pu Liao 7, Jing-Fu Qiu 8, Yong Lin 1, Xue-Fei Cai 1, De-Qiang Wang 1, Yuan Hu 1, Ji-Hua Ren 1, Ni Tang 1, Yin-Yin Xu 2, Li-Hua Yu 2, Zhan Mo 2, Fang Gong 2, Xiao-Li Zhang 2, Wen-Guang Tian 2, Li Hu 2, Xian-Xiang Zhang 3 4, Jiang-Lin Xiang 3 4, Hong-Xin Du 3 4, Hua-Wen Liu 3 4, Chun-Hui Lang 3 4, Xiao-He Luo 3 4, Shao-Bo Wu 3 4, Xiao-Ping Cui 3 4, Zheng Zhou 3 4, Man-Man Zhu 5, Jing Wang 6, Cheng-Jun Xue 6, Xiao-Feng Li 6, Li Wang 6, Zhi-Jie Li 7, Kun Wang 7, Chang-Chun Niu 7, Qing-Jun Yang 7, Xiao-Jun Tang 8, Yong Zhang 8, Xia-Mao Liu 9, Jin-Jing Li 9, De-Chun Zhang 10, Fan Zhang 10, Ping Liu 11, Jun Yuan 1, Qin Li 12, Jie-Li Hu 13, Juan Chen 14, Ai-Long Huang 15
Affiliations
- PMID: 32350462
- DOI: 10.1038/s41591-020-0897-1
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al. Nat Med. 2020 Jun.
Abstract
We report acute antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within 19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G (IgG). Seroconversion for IgG and IgM occurred simultaneously or sequentially. Both IgG and IgM titers plateaued within 6 days after seroconversion. Serological testing may be helpful for the diagnosis of suspected patients with negative RT-PCR results and for the identification of asymptomatic infections.
Similar articles
- Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
Suhandynata RT, Hoffman MA, Kelner MJ, McLawhon RW, Reed SL, Fitzgerald RL. Suhandynata RT, et al. J Appl Lab Med. 2020 Sep 1;5(5):908-920. doi: 10.1093/jalm/jfaa079. J Appl Lab Med. 2020. PMID: 32428207 Free PMC article. - SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
Phipps WS, SoRelle JA, Li QZ, Mahimainathan L, Araj E, Markantonis J, Lacelle C, Balani J, Parikh H, Solow EB, Karp DR, Sarode R, Muthukumar A. Phipps WS, et al. Am J Clin Pathol. 2020 Sep 8;154(4):459-465. doi: 10.1093/ajcp/aqaa123. Am J Clin Pathol. 2020. PMID: 32666092 Free PMC article. - Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test.
Dortet L, Emeraud C, Vauloup-Fellous C, Khecharem M, Ronat JB, Fortineau N, Roque-Afonso AM, Naas T. Dortet L, et al. Emerg Microbes Infect. 2020 Dec;9(1):2212-2221. doi: 10.1080/22221751.2020.1826892. Emerg Microbes Infect. 2020. PMID: 32969769 Free PMC article. - Value and Validity of Coronavirus Antibody Testing.
Mahajan A, Manchikanti L. Mahajan A, et al. Pain Physician. 2020 Aug;23(4S):S381-S390. Pain Physician. 2020. PMID: 32942795 Review. - Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments.
Goodarzi P, Mahdavi F, Mirzaei R, Hasanvand H, Sholeh M, Zamani F, Sohrabi M, Tabibzadeh A, Jeda AS, Niya MHK, Keyvani H, Karampoor S. Goodarzi P, et al. Int Immunopharmacol. 2020 Nov;88:106885. doi: 10.1016/j.intimp.2020.106885. Epub 2020 Aug 8. Int Immunopharmacol. 2020. PMID: 32795893 Free PMC article. Review.
Cited by
- Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.
Xiao N, Nie M, Pang H, Wang B, Hu J, Meng X, Li K, Ran X, Long Q, Deng H, Chen N, Li S, Tang N, Huang A, Hu Z. Xiao N, et al. Nat Commun. 2021 Mar 12;12(1):1618. doi: 10.1038/s41467-021-21907-9. Nat Commun. 2021. PMID: 33712622 Free PMC article. - Antibody Levels Poorly Reflect on the Frequency of Memory B Cells Generated following SARS-CoV-2, Seasonal Influenza, or EBV Infection.
Wolf C, Köppert S, Becza N, Kuerten S, Kirchenbaum GA, Lehmann PV. Wolf C, et al. Cells. 2022 Nov 18;11(22):3662. doi: 10.3390/cells11223662. Cells. 2022. PMID: 36429090 Free PMC article. - SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology.
Sahu AK, Sreepadmanabh M, Rai M, Chande A. Sahu AK, et al. Virusdisease. 2021 Mar;32(1):1-12. doi: 10.1007/s13337-021-00653-y. Epub 2021 Feb 22. Virusdisease. 2021. PMID: 33644261 Free PMC article. Review. - Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients.
Pflüger LS, Bannasch JH, Brehm TT, Pfefferle S, Hoffmann A, Nörz D, van der Meirschen M, Kluge S, Haddad M, Pischke S, Hiller J, Addo MM, Lohse AW, Schulze Zur Wiesch J, Peine S, Aepfelbacher M, Lütgehetmann M. Pflüger LS, et al. J Clin Virol. 2020 Sep;130:104549. doi: 10.1016/j.jcv.2020.104549. Epub 2020 Jul 17. J Clin Virol. 2020. PMID: 32763809 Free PMC article. - Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.
Hu J, Gao Q, He C, Huang A, Tang N, Wang K. Hu J, et al. Genes Dis. 2020 Dec;7(4):551-557. doi: 10.1016/j.gendis.2020.07.006. Epub 2020 Jul 17. Genes Dis. 2020. PMID: 32837985 Free PMC article.
References
- Corman, V. M. et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin. Infect. Dis. 62, 477–483 (2016). - PubMed
- Li, G., Chen, X. & Xu, A. Profile of specific antibodies to the SARS-associated coronavirus. N. Engl. J. Med. 349, 508–509 (2003). - DOI
- Hsueh, P. R., Huang, L. M., Chen, P. J., Kao, C. L. & Yang, P. C. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin. Microbiol. Infect. 10, 1062–1066 (2004). - DOI
- Park, W. B. et al. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea. Emerg. Infect. Dis. 21, 2186–2189 (2015). - DOI
- Drosten, C. et al. Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 371, 828–835 (2014). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous